ATP5F1B and prostate carcinoma: In aprevious study, the ATP5B-specific binding peptide B04 was shown to inhibit the migrationand invasion of prostate cancer cells, and the expression of ATP5B on the plasma membrane ofMDA-MB-231 cells was confirmed.